Earley E, Didriksen M, Spencer B, Kiss J, Erikstrup C, Pedersen O
Sleep. 2020; 44(4).
PMID: 33119070
PMC: 8033459.
DOI: 10.1093/sleep/zsaa220.
Chen P, Ijomone O, Lee K, Aschner M
Adv Pharmacol. 2019; 84:147-174.
PMID: 31229169
PMC: 6592618.
DOI: 10.1016/bs.apha.2018.12.003.
Catoire H, Sarayloo F, Mourabit Amari K, Apuzzo S, Grant A, Rochefort D
Sci Rep. 2018; 8(1):12173.
PMID: 30111810
PMC: 6093889.
DOI: 10.1038/s41598-018-30665-6.
Kang S, Lee Y, Park Y, Kim L, Lee H
Psychiatry Investig. 2018; 15(1):84-89.
PMID: 29422930
PMC: 5795036.
DOI: 10.4306/pi.2018.15.1.84.
Winkelman J, Blackwell T, Stone K, Ancoli-Israel S, Tranah G, Redline S
Sleep Med. 2015; 16(11):1360-1365.
PMID: 26498236
PMC: 4621485.
DOI: 10.1016/j.sleep.2015.07.017.
MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome.
Roco A, Jimenez-Jimenez F, Alonso-Navarro H, Martinez C, Zurdo M, Turpin-Fenoll L
J Neural Transm (Vienna). 2012; 120(3):463-7.
PMID: 23001634
DOI: 10.1007/s00702-012-0897-5.
Dilution of candidates: the case of iron-related genes in restless legs syndrome.
Oexle K, Schormair B, Ried J, Czamara D, Heim K, Frauscher B
Eur J Hum Genet. 2012; 21(4):410-4.
PMID: 22929029
PMC: 3598324.
DOI: 10.1038/ejhg.2012.193.
Association studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US population.
Yang Q, Li L, Chen Q, Foldvary-Schaefer N, Ondo W, Wang Q
Sleep Med. 2011; 12(8):800-4.
PMID: 21925394
PMC: 3514407.
DOI: 10.1016/j.sleep.2011.06.006.
MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease.
Schormair B, Plag J, Kaffe M, Gross N, Czamara D, Samtleben W
J Med Genet. 2011; 48(7):462-6.
PMID: 21572129
PMC: 3122881.
DOI: 10.1136/jmg.2010.087858.
Genome-wide association studies of sleep disorders.
Raizen D, Wu M
Chest. 2011; 139(2):446-452.
PMID: 21285061
PMC: 3032368.
DOI: 10.1378/chest.10-1313.
Whole genome association studies in complex diseases: where do we stand?.
Need A, Goldstein D
Dialogues Clin Neurosci. 2010; 12(1):37-46.
PMID: 20373665
PMC: 3181943.
MEIS1 p.R272H in familial restless legs syndrome.
Vilarino-Guell C, Chai H, Keeling B, Young J, Rajput A, Lynch T
Neurology. 2009; 73(3):243-5.
PMID: 19620614
PMC: 2715576.
DOI: 10.1212/WNL.0b013e3181ae7c79.
Replication of restless legs syndrome loci in three European populations.
Kemlink D, Polo O, Frauscher B, Gschliesser V, Hogl B, Poewe W
J Med Genet. 2009; 46(5):315-8.
PMID: 19279021
PMC: 2695663.
DOI: 10.1136/jmg.2008.062992.
Clinical and genetic description of a family with a high prevalence of autosomal dominant restless legs syndrome.
Young J, Vilarino-Guell C, Lin S, Wszolek Z, Farrer M
Mayo Clin Proc. 2009; 84(2):134-8.
PMID: 19181647
PMC: 2664577.
DOI: 10.4065/84.2.134.
MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels.
Xiong L, Catoire H, Dion P, Gaspar C, Lafreniere R, Girard S
Hum Mol Genet. 2009; 18(6):1065-74.
PMID: 19126776
PMC: 2722232.
DOI: 10.1093/hmg/ddn443.
Genome-wide association studies in neurological disorders.
Simon-Sanchez J, Singleton A
Lancet Neurol. 2008; 7(11):1067-72.
PMID: 18940696
PMC: 2824165.
DOI: 10.1016/S1474-4422(08)70241-2.
